SEC Form 4 · accession 0001209191-15-084826
Anacor Pharmaceuticals, Inc. · ANAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryan T Sullivan
Officer — Sr. VP and General Counsel
Period of report
Dec 10, 2015
Accepted (ET)
Dec 11, 2015 · 7:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 10, 2015 | M | 10,000 | $15.30 | A | 37,740 | D | |
| Common StockF2 | Dec 10, 2015 | S | 1,100 | $108.9034 | D | 36,640 | D | |
| Common StockF3 | Dec 10, 2015 | S | 4,900 | $110.2467 | D | 31,740 | D | |
| Common StockF4 | Dec 10, 2015 | S | 4,000 | $111.0256 | D | 27,740 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F5 | $15.30 | Dec 10, 2015 | M | 10,000 | D | — | Apr 28, 2024 | Common Stock | 10,000 | 30,000 | D |
Explanation of responses
- F1This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.57 to $109.305, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.50, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.00 to $111.26, inclusive.
- F5The award is subject to a four-year vesting period, with 25% of the shares subject to the award vesting in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting each month thereafter. The Vesting Commencement Date was April 28, 2014.